| Range: | 0.19-3.56 | Vol Avg: | 2844681 | Last Div: | 0 | Changes: | 0.02 |
| Beta: | 4.68 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Jan 14 2022 | Empoloyees: | 7 | ||
| CUSIP: | 14159C103 | CIK: | 0001870144 | ISIN: | US14159C1036 | Country: | US |
| CEO: | Dr. Meeshanthini V. Dogan Ph.D. | Website: | https://cardiodiagnosticsinc.com | ||||
CDIO 0.32 Stock Price Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow